Oasis Diagnostics S.A.

Research and experimental development in natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-01-25
Share capital
208,046.00 PLN
Activity description

OASIS Diagnostics SA is a MedTech company focused on women’s health. It develops ONIRY, a one-minute test used right after delivery to detect obstetric anal sphincter injuries (OASI) and assess the risk of fecal incontinence. The system is described as an early postpartum diagnostic tool with a tiny probe for patient comfort.

Registered address
ul. Czerska 8/10/313, 00-732 Warszawa, Poland
Email
Social media
Electronic delivery address
AE:PL-83359-91519-CAJUG-24

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 1 of 6 financial statements was filed late (for 2021, 55 days late). All were audited by a statutory auditor.

  • 2025not filed
  • 202403/07/2025
  • 202327/05/2024
  • 202230/06/2023
  • 202108/09/2022
  • 202030/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Top 32%
Top 32%
Voivodeship · Mazowieckie58,614 / 142,215
Top 41%
Country · Poland213,252 / 496,512
Top 43%

Results vs industry

Revenue
This companyUSD 282.61kMedianUSD 153.26kAverageUSD 4.77m
Net profit
This companyUSD -1.76mMedianUSD -293.45AverageUSD 306.55k
Operating costs
This companyUSD 1.98mMedianUSD 188.47kAverageUSD 4.59m
Assets
This companyUSD 3.56mMedianUSD 281.58kAverageUSD 8.35m

News

Conference in the Czech Republic

Conference in the Czech Republic

We are seeing a growing willingness within the Czech obstetrics community to look more closely at how postpartum assessment is carried out in practice.

Symposium in Turkey

Symposium in Turkey

We had the pleasure of participating in the Eskişehir Urogynecology Symposium (April 11–12), where our KOL, Dr. Małgorzata Uchman-Musielak, shared clinical insights on the importance of early detection of obstetric anal sphincter injuries (OASI).

Regulatory milestone: our system registered in Turkey

Regulatory milestone: our system registered in Turkey

We are pleased to announce that our EU MDR-certified postpartum diagnostic platform has officially completed medical device registration in Turkey, and our Spectrometer and Probe are now fully registered as medical devices in Turkish market!

Postpartum perineal diagnostics is entering public discussion in Central Europe

Postpartum perineal diagnostics is entering public discussion in Central Europe

Last week, Prof. Hynek Herman spoke on Czech national television about the diagnostic challenges in obstetric anal sphincter injuries (OASI) and the potential role of impedance spectroscopy in early detection.

Polish FemTech 2025 Map

Polish FemTech 2025 Map

We are honoured to have been included in the First Map of Polish Femtech in the Pelvic Floor Health, Pregnancy and Labour category! The link to the LinkedIn post: https://www.linkedin.com/posts/femtech-po-polsku_mapa-polskiego-femtechu-2025-polish-femtech-activity-7404872782502711296-HTsd?utm_source=share&utm_medium=member_desktop&rcm=ACoAAA7X1aEBUORr0zdxvdN8OdK1g6rfDob4A9I

New distribution collaboration in Hungary

New distribution collaboration in Hungary

We are excited to share that OASIS Diagnostics is starting a new collaboration in Hungary 🇭🇺 with Hueso Medical Kft.

Offer

  • Diagnostic system
  • Spectrometer
  • Diagnostic probe
  • Stand
  • Diagnostic app

Websites

Authorized Representatives

Katarzyna Borycka age 53 – President of the Management Board
Marcel Młyńczak age 36 – Management Board Member

Manner of representation

Two members of the management board acting jointly are authorized to make declarations of will on behalf of the company and to represent the company.

Supervisory board

Aleksander Woźnicki age 48 – Supervisory Board Member
Krystyna Danuta Węglorz-Grygier age 57 – Supervisory Board Member
Jacek Mieczkowski age 49 – Supervisory Board Member
Monika Prokopowicz age 40 – Supervisory Board Member
Piotr Wojciech Pietrzak age 47 – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2018-03-12.

  • mBank
    12 1140 1010 0000 3870 7200 1001
  • mBank
    82 1140 1010 0000 3870 7200 1002
  • mBank
    98 1140 1010 0000 3870 7200 1005

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Nov 18, 2019Commercial Companies Code notice

Public aid

9 public aid cases recorded, with a total value of $1,649,189.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,973
Aid for SMEs for innovation support
$12,973
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,973

Competitors

Name
Przedsiębiorstwo Wdrożeniowo - Produkcyjne Sonomed sp. z o.o.
Medicalgorithmics Polska sp. z o.o.
Przedsiębiorstwo Usługowo-Handlowe Medea Spólka z Ograniczoną Odpowiedzialnością sp. z o.o.
PRO-Plus S.A.
Abcmed sp. z o.o.
Medisensonic S.A.
GSOC sp. z o.o.
Envcheck sp. z o.o.
Gierth sp. z o.o.
Invinets sp. z o.o.

Change history

DateEvent
2025-07-21Share capital reduction
2025-05-16Share capital increase
2023-12-07Address change
2023-10-18Share capital increase
2023-03-28Share capital increase

FAQ

Last updated: 2026-07-12